Akita H, Kobayashi S, Yamada D, Tomimaru Y, et al. Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patients with resectable and borderline resectable pancreatic cancer: A post hoc analysis of 2 phase II trials. Surgery 2025;190:109864.
PMID: 41232280